Robin Alfonso Buys 768 Shares of CVS Group (LON:CVSG) Stock

Key Points

• Robin Alfonso purchased 768 CVS Group shares at an average price of GBX 1,294, investing approximately £9,938.
• CVS Group shares rose 0.5% to GBX 1,295, while trading volume remained well below the stock’s average; the company has a market capitalization of about £896 million and a P/E ratio of 18.8.
• Analysts maintain a broadly positive outlook, with four Buy ratings and one Hold rating, producing a “Moderate Buy” consensus and an average price target of GBX 1,720.

CVS Group plc (LON:CVSG - Get Free Report) insider Robin Alfonso acquired 768 shares of CVS Group stock in a transaction that occurred on Thursday, August 6th. The shares were purchased at an average price of GBX 1,294 per share, with a total value of £9,937.92.

CVS Group Stock Up 0.5%

Shares of CVS Group stock traded up GBX 6 during trading on Thursday, reaching GBX 1,295. The company's stock had a trading volume of 81,360 shares, compared to its average volume of 965,233. CVS Group plc has a 1-year low of GBX 1,062 and a 1-year high of GBX 1,648. The company has a 50-day simple moving average of GBX 1,231.89 and a two-hundred day simple moving average of GBX 1,242.49. The company has a quick ratio of 0.90, a current ratio of 1.07 and a debt-to-equity ratio of 92.34. The company has a market cap of £896.14 million, a price-to-earnings ratio of 18.80, a P/E/G ratio of 1.77 and a beta of 1.06.

CVS Group announced that its board has approved a stock buyback program on Tuesday, May 26th that authorizes the company to buyback 0 shares. This buyback authorization authorizes the company to purchase shares of its stock through open market purchases. Stock buyback programs are typically a sign that the company's management believes its stock is undervalued.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Berenberg Bank restated a "buy" rating and issued a GBX 2,000 target price on shares of CVS Group in a research note on Thursday, July 23rd. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and set a GBX 1,700 price target on shares of CVS Group in a research note on Monday, July 27th. Finally, Jefferies Financial Group raised their price objective on CVS Group from GBX 1,350 to GBX 1,400 and gave the stock a "hold" rating in a research note on Friday, July 31st. Four investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of GBX 1,720.

CVS Group Company Profile

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy. The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct"). The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source